ClinicalTrials.Veeva

Menu

Biomarkers Correlation With Volemia (ENVOL)

B

B·R·A·H·M·S

Status

Completed

Conditions

Cerebral Hemorrhage
Head Injury
Poly Trauma Patients Without Heart Failure
Non Traumatic Post Surgery
Renal Insufficiency

Treatments

Other: Biomarkers, red blood cells and plasma assessment

Study type

Interventional

Funder types

Industry

Identifiers

NCT01858675
2011-A01310-41

Details and patient eligibility

About

The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro Endothelin) changes at Day 2, Day 5 and Day 7 of ICU admission are correlated with Intravascular volume assessed by Cr 51 on red blood cells (Day 2 and Day 7) and by I 125 on albumine Day 7. The correlation of these Biomarkers are also evaluted with other markers such as erythropoietin and catecholamines. 80 ICU patients are included.

Enrollment

66 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 20 Cerebral Hemorrhage
  • 20 Head Injury
  • 20 post surgery non traumatic non neuro
  • 20 Polytrauma patients

Exclusion criteria

  • Heart failure NYHA III or IV
  • Renal insufficiency creatinin clearance < 30 ml/mn
  • age < 18 Y
  • Pregnancy

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

66 participants in 1 patient group

Biomarkers, total blood volume
Experimental group
Treatment:
Other: Biomarkers, red blood cells and plasma assessment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems